Anzeige
Mehr »
Samstag, 28.06.2025 - Börsentäglich über 12.000 News
Diese KI-Biotech-Aktie revolutioniert die Krebstherapie: Lernen Sie Rakovina Therapeutics kennen
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A12CPC | ISIN: SE0005250719 | Ticker-Symbol: A6X
Frankfurt
27.06.25 | 08:07
0,208 Euro
0,00 % 0,000
Branche
Chemie
Aktienmarkt
Sonstige
1-Jahres-Chart
AXICHEM AB Chart 1 Jahr
5-Tage-Chart
AXICHEM AB 5-Tage-Chart

Aktuelle News zur AXICHEM Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
AXICHEM Aktie jetzt für 0€ handeln
18.06.aXichem AB: Resolutions from the 2025 Annual General Meeting of aXichem AB (publ)496aXichem AB (publ), corporate registration number 556739-8663 (the "Company"), held its Annual General Meeting on Wednesday, June 18, 2025 at 10:00 a.m. in Malmö. The following is an account of the main...
► Artikel lesen
12.06.aXichem AB: aXichem announces positive results of completed efficacy studies, as well as time for submission of supplemented Feed Additive application in the EU57aXichem AB (publ), developer of innovative natural analogue feed additives and dietary supplement ingredients, announces that it has successfully completed the efficacy studies that form part of the...
► Artikel lesen
22.05.aXichem AB: aXichem AB (publ), Interim Report January - March 202590aXichem's development during the period 2025-01-01-2025-03-31 In this interim report, the aXichem group is presented, which consists of aXichem AB (publ), Incendia Pharma AB and aXichem AS (Norway)....
► Artikel lesen
12.05.aXichem AB: aXichem receives first call-off order for aXiphen from Chr. Olesen after successful tests in Brazil87aXichem AB (publ), (aXichem), the developer of innovative feed additives and food supplement ingredients, announces that the Company, after very successful tests at a major chicken meat production facility...
► Artikel lesen
16.04.aXichem AB: aXichem appoints Erik Lager as Chief Operating Officer, to meet the growth phase's increased need for a quality-assured delivery process105aXichem AB (publ), (aXichem), developer of innovative natural analogue feed additives and dietary supplement ingredients, announces that the company, which is entering a growth phase and seeing increased...
► Artikel lesen
05.03.aXichem AB: aXichem Announces Preliminary Findings from CrossFit Performance Study with aXivite, Indicating Unmatched Endurance and Recovery Gains325aXichem AB (publ), (aXichem), the developer of innovative natural analogue feed additives and food supplement ingredients, announces exciting preliminary results from its latest randomized, placebo-controlled...
► Artikel lesen
27.02.aXichem AB: aXichem AB (publ) Year End Report, January - December 2024214aXichem's development during the period 2024-01-01-2024-12-31 In this interim report, the aXichem group is presented, which consists of aXichem AB (publ), Incendia Pharma AB and aXichem AS (Norway)....
► Artikel lesen
04.02.aXichem AB: aXichem updates status regarding completion of Feed Additive application in the EU for phenylcapsaicin151aXichem AB (publ), developer of innovative natural analogue feed additives and dietary supplement ingredients, announces that the company will increase the number of studies, regarding effect, that...
► Artikel lesen
28.11.24aXichem AB: aXichem AB (publ), Interim Report January - September 2024146aXichem's development during the period 2024-01-01-2024-09-30 In this interim report, the aXichem group is presented, which consists of aXichem AB (publ), Incendia Pharma AB and aXichem AS (Norway)....
► Artikel lesen
27.08.24aXichem AB: aXichem AB (publ), Interim Report January - June 2024119aXichem's development during the period 2024-01-01-2024-06-30 In this interim report, the aXichem group is presented, which consists of aXichem AB (publ), Incendia Pharma AB and aXichem AS (Norway)....
► Artikel lesen
10 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1